85.3 USD
+0.53 (+0.63%)
84.01 USD
-1.29 (-1.51%)
We assign a fundamental rating of 5 out of 10 to GEHC. GEHC was compared to 185 industry peers in the Health Care Equipment & Supplies industry. While GEHC has a great profitability rating, there are quite some concerns on its financial health. GEHC is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year GEHC was profitable.
- GEHC had a positive operating cash flow in the past year.
- Each year in the past 5 years GEHC has been profitable.
- GEHC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- GEHC has a Return On Assets of 6.14%. This is amongst the best in the industry. GEHC outperforms 84.32% of its industry peers.
- GEHC's Return On Equity of 22.19% is amongst the best of the industry. GEHC outperforms 95.14% of its industry peers.
- With an excellent Return On Invested Capital value of 7.77%, GEHC belongs to the best of the industry, outperforming 83.78% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for GEHC is in line with the industry average of 8.84%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.14% | ||
| ROE | 22.19% | ||
| ROIC | 7.77% |
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
1.3 Margins
- GEHC has a better Profit Margin (10.95%) than 84.86% of its industry peers.
- GEHC's Profit Margin has improved in the last couple of years.
- GEHC's Operating Margin of 13.52% is amongst the best of the industry. GEHC outperforms 81.62% of its industry peers.
- GEHC's Operating Margin has been stable in the last couple of years.
- With a Gross Margin value of 40.80%, GEHC is not doing good in the industry: 66.49% of the companies in the same industry are doing better.
- GEHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.52% | ||
| PM (TTM) | 10.95% | ||
| GM | 40.8% |
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
2. Health
2.1 Basic Checks
- GEHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for GEHC has been increased compared to 1 year ago.
- Compared to 1 year ago, GEHC has an improved debt to assets ratio.
2.2 Solvency
- GEHC has an Altman-Z score of 1.95. This is not the best score and indicates that GEHC is in the grey zone with still only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 1.95, GEHC is in line with its industry, outperforming 58.92% of the companies in the same industry.
- The Debt to FCF ratio of GEHC is 7.38, which is on the high side as it means it would take GEHC, 7.38 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 7.38, GEHC is in the better half of the industry, outperforming 75.14% of the companies in the same industry.
- GEHC has a Debt/Equity ratio of 0.83. This is a neutral value indicating GEHC is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.83, GEHC is doing worse than 72.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | 7.38 | ||
| Altman-Z | 1.95 |
ROIC/WACC0.8
WACC9.69%
2.3 Liquidity
- A Current Ratio of 1.18 indicates that GEHC should not have too much problems paying its short term obligations.
- GEHC's Current ratio of 1.18 is on the low side compared to the rest of the industry. GEHC is outperformed by 81.62% of its industry peers.
- A Quick Ratio of 0.95 indicates that GEHC may have some problems paying its short term obligations.
- GEHC's Quick ratio of 0.95 is on the low side compared to the rest of the industry. GEHC is outperformed by 78.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 0.95 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 8.77% over the past year.
- Measured over the past 5 years, GEHC shows a small growth in Earnings Per Share. The EPS has been growing by 5.32% on average per year.
- GEHC shows a small growth in Revenue. In the last year, the Revenue has grown by 3.52%.
- Measured over the past years, GEHC shows a small growth in Revenue. The Revenue has been growing by 3.41% on average per year.
EPS 1Y (TTM)8.77%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%-6.14%
Revenue 1Y (TTM)3.52%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%5.76%
3.2 Future
- The Earnings Per Share is expected to grow by 7.54% on average over the next years.
- The Revenue is expected to grow by 3.87% on average over the next years.
EPS Next Y2.67%
EPS Next 2Y5.64%
EPS Next 3Y7.56%
EPS Next 5Y7.54%
Revenue Next Year4.16%
Revenue Next 2Y4.25%
Revenue Next 3Y4.32%
Revenue Next 5Y3.87%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 18.58, GEHC is valued on the expensive side.
- Based on the Price/Earnings ratio, GEHC is valued cheaply inside the industry as 83.24% of the companies are valued more expensively.
- The average S&P500 Price/Earnings ratio is at 27.33. GEHC is valued slightly cheaper when compared to this.
- A Price/Forward Earnings ratio of 17.02 indicates a rather expensive valuation of GEHC.
- Based on the Price/Forward Earnings ratio, GEHC is valued cheaper than 85.41% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.12, GEHC is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.58 | ||
| Fwd PE | 17.02 |
4.2 Price Multiples
- GEHC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GEHC is cheaper than 84.32% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, GEHC is valued cheaply inside the industry as 82.16% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.75 | ||
| EV/EBITDA | 13.65 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The decent profitability rating of GEHC may justify a higher PE ratio.
PEG (NY)6.96
PEG (5Y)3.49
EPS Next 2Y5.64%
EPS Next 3Y7.56%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.16%, GEHC is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.19, GEHC pays a better dividend. On top of this GEHC pays more dividend than 89.73% of the companies listed in the same industry.
- With a Dividend Yield of 0.16, GEHC pays less dividend than the S&P500 average, which is at 1.91.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.16% |
5.2 History
- GEHC has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- GEHC pays out 2.80% of its income as dividend. This is a sustainable payout ratio.
DP2.8%
EPS Next 2Y5.64%
EPS Next 3Y7.56%
85.3
+0.53 (+0.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29 2025-10-29/bmo
Earnings (Next)02-04 2026-02-04/bmo
Inst Owners89.01%
Inst Owner Change0.23%
Ins Owners0.28%
Ins Owner Change-0.04%
Market Cap38.86B
Revenue(TTM)20.25B
Net Income(TTM)2.22B
Analysts79.29
Price Target91.51 (7.28%)
Short Float %2.59%
Short Ratio3.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.16% |
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP2.8%
Div Incr Years1
Div Non Decr Years1
Ex-Date01-09 2026-01-09 (0.035)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.54%
Min EPS beat(2)-0.16%
Max EPS beat(2)13.24%
EPS beat(4)3
Avg EPS beat(4)8.5%
Min EPS beat(4)-0.16%
Max EPS beat(4)13.24%
EPS beat(8)6
Avg EPS beat(8)5.72%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.92%
Min Revenue beat(2)-1.09%
Max Revenue beat(2)-0.75%
Revenue beat(4)1
Avg Revenue beat(4)-0.9%
Min Revenue beat(4)-2.17%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-1.64%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.16%
PT rev (3m)2.45%
EPS NQ rev (1m)0.23%
EPS NQ rev (3m)-0.55%
EPS NY rev (1m)0.06%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-0.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.58 | ||
| Fwd PE | 17.02 | ||
| P/S | 1.92 | ||
| P/FCF | 27.75 | ||
| P/OCF | 21 | ||
| P/B | 3.89 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.65 |
EPS(TTM)4.59
EY5.38%
EPS(NY)5.01
Fwd EY5.87%
FCF(TTM)3.07
FCFY3.6%
OCF(TTM)4.06
OCFY4.76%
SpS44.45
BVpS21.94
TBVpS-10.12
PEG (NY)6.96
PEG (5Y)3.49
Graham Number47.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.14% | ||
| ROE | 22.19% | ||
| ROCE | 10.51% | ||
| ROIC | 7.77% | ||
| ROICexc | 9.18% | ||
| ROICexgc | 27.2% | ||
| OM | 13.52% | ||
| PM (TTM) | 10.95% | ||
| GM | 40.8% | ||
| FCFM | 6.91% |
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
ROICexc(3y)9.28%
ROICexc(5y)10.16%
ROICexgc(3y)32.48%
ROICexgc(5y)41.69%
ROCE(3y)11.31%
ROCE(5y)12.72%
ROICexgc growth 3Y-14.77%
ROICexgc growth 5YN/A
ROICexc growth 3Y-4.79%
ROICexc growth 5YN/A
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | 7.38 | ||
| Debt/EBITDA | 2.51 | ||
| Cap/Depr | 78.67% | ||
| Cap/Sales | 2.22% | ||
| Interest Coverage | 5.09 | ||
| Cash Conversion | 55.91% | ||
| Profit Quality | 63.15% | ||
| Current Ratio | 1.18 | ||
| Quick Ratio | 0.95 | ||
| Altman-Z | 1.95 |
F-Score5
WACC9.69%
ROIC/WACC0.8
Cap/Depr(3y)60.52%
Cap/Depr(5y)52.47%
Cap/Sales(3y)1.9%
Cap/Sales(5y)1.73%
Profit Quality(3y)98.54%
Profit Quality(5y)74.63%
High Growth Momentum
Growth
EPS 1Y (TTM)8.77%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%-6.14%
EPS Next Y2.67%
EPS Next 2Y5.64%
EPS Next 3Y7.56%
EPS Next 5Y7.54%
Revenue 1Y (TTM)3.52%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%5.76%
Revenue Next Year4.16%
Revenue Next 2Y4.25%
Revenue Next 3Y4.32%
Revenue Next 5Y3.87%
EBIT growth 1Y8.91%
EBIT growth 3Y-2.07%
EBIT growth 5Y4.33%
EBIT Next Year18.28%
EBIT Next 3Y10.99%
EBIT Next 5Y9.55%
FCF growth 1Y-18.75%
FCF growth 3Y4.48%
FCF growth 5Y0.56%
OCF growth 1Y-11.61%
OCF growth 3Y6.68%
OCF growth 5Y1.2%
GE HEALTHCARE TECHNOLOGY / GEHC FAQ
What is the fundamental rating for GEHC stock?
ChartMill assigns a fundamental rating of 5 / 10 to GEHC.
What is the valuation status for GEHC stock?
ChartMill assigns a valuation rating of 6 / 10 to GE HEALTHCARE TECHNOLOGY (GEHC). This can be considered as Fairly Valued.
How profitable is GE HEALTHCARE TECHNOLOGY (GEHC) stock?
GE HEALTHCARE TECHNOLOGY (GEHC) has a profitability rating of 7 / 10.
What is the financial health of GE HEALTHCARE TECHNOLOGY (GEHC) stock?
The financial health rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10.
Can you provide the dividend sustainability for GEHC stock?
The dividend rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10 and the dividend payout ratio is 2.8%.